Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Sumatriptan Succinate

Known as: Succinate, Sumatriptan, Sumatriptan Succinate [Chemical/Ingredient] 
The succinate salt form of sumatriptan, a member of the triptan class of compounds with anti-migraine property. Sumatriptan succinate selectively… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2013
Highly Cited
2013
Sublingual administration of active pharmaceutical substances is in principle favourable for rapid onset of drug action, ready… Expand
Highly Cited
2008
Highly Cited
2008
The purpose of this study was to develop and optimize formulations of mucoadhesive bilayered buccal patches of sumatriptan… Expand
  • table I
  • table II
  • table III
  • figure 1
  • table IV
Highly Cited
2008
Highly Cited
2008
The purpose of the present study was to develop intranasal delivery systems of sumatriptan using thermoreversible polymer… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Highly Cited
2007
Highly Cited
2007
CONTEXT Multiple pathogenic mechanisms may be involved in generating the migraine symptom complex, and multimechanism-targeted… Expand
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Highly Cited
2005
Highly Cited
2005
The effects of percutaneous enhancers on the transdermal absorption of sumatriptan succinate were investigated by in vitro… Expand
Highly Cited
1998
Highly Cited
1998
OBJECTIVE To evaluate the impact of sumatriptan succinate injection compared with placebo on productivity loss during a migraine… Expand
  • figure 1
  • table 1
  • figure 2
  • table 2
  • figure 3
Highly Cited
1998
Highly Cited
1998
Sumatriptan succinate, a serotonin-1 (5-hydroxytryptamine-1) receptor agonist, is an antimigraine drug that is reported to act by… Expand
Highly Cited
1996
Highly Cited
1996
BACKGROUND Rizatriptan (MK-462) is a new 5-hydroxytryptamine1D (serotonin1D; 5-HT1D) receptor agonist for the acute treatment of… Expand
Highly Cited
1996
Highly Cited
1996
OBJECTIVE To assess the efficacy and tolerability of subcutaneous dihydroergotamine mesylate (DHE-45) vs subcutaneous sumatriptan… Expand
Highly Cited
1991
Highly Cited
1991
Sumatriptan succinate, a 5-HT1D receptor agonist, constricts human cranial arteries. Two parallel-group trials for treatment of… Expand
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3